[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Indexing Databases::
Editorial Board::
Executive Members::
Instruction to Authors::
Peer Review::
Articles Archive::
Contact Us::
Site Facilities::
::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
:: Search published articles ::
Showing 2 results for Indomethacin

M.asgharnia (m.d), A.sobhani (m.d), Z.omidvar-Jalali (m.d),
Volume 4, Issue 2 (9-2002)
Abstract

A great number of drugs have been used to inhibit preterm labor but none has been completely effective. This study has compared. The efficacy of Indomethacin and Mg-Sulfate for delaying delivery in preterm labor. In this randomized controlled trial study 120 pregnant women with intact membrane and preterm labor, cervical dilatation at least 2 cm were studied and if they had premature rupture of membranes, gestational age less than 24 or more than 32 weeks, complete cervical dilatation, severe hemorrhage, chorioamnionitis and triple or higher order gestation excluded from study. Subjects are randomly managed with Indomethacin 25 mg every 6 hours for 4 doses or Mg-Sulfate initially 4 gr/IV followed by 2 gr/h IU infusion until uterine activity diminished or decrease. The success of management was considered as either reduce or stopping the uterine contractions, and no increase in cervical dilatation or effacement. Statistical analysis were performed with Chi-square and T-test. The 2 groups understudy had the same inducer maternal matched maternal age, gestational age, parity, dilatation and effacement at initiation of study, frequency of uterine contractions. Delivery was delayed 24 hr in 66.6% and 48 hr in 58.3% by Mg-Sulfate, also delayed 24 hr in 40% and 48hr in 35% by Indomethacin (P<0.0001). No complications were reported in each group. Mg-Sulfate is more effective than Indomethacin in delaying preterm labor.
Jalilzadeh-Amin G, Yousefi Ar, Abdollahi-Pirbazari M,
Volume 16, Issue 2 (7-2014)
Abstract

Background and Objective: Bunium percicum is often used in Iranian traditional medicine for the treatment of gastrointestinal disorders particularly gastric ulcer.This study was done to evaluate the antiulcerogenic effect of Bunium percicum Boiss.essential oil against indomethacin and ethanol – induced ulcer models in Wistar rats. Methods: This experimental study was carried out on rats weighing 200-220 g in veterinary college of Urmia University, Iran. LD50 was calculated based on Lorke’s method. To evaluate the short term oral toxicity, animals were allocated into four group of six each. In groups 1-3 animals were received orally 250, 125, 80 mg/kg/bw of Bunium percicum Boiss.essential oil, respectively. Controls were received Tween 80 (2%) orally for 14 consecutive days and monitored daily. Bunium percicum Boiss. essential oil was administered orally at doses of 20, 40 and 80 mg/kg/bw and cimetedin (10 mg/kg/bw) and omopirazol (30 mg/kg/bw) in indomethacin and ethanol–induced ulcer models. Results: The LD50 was 375 mg/kg/bw. Daily single oral doses of Bunium percicum Boiss.essential oil tolerated behaviorally after 14 days without any alterations in body and organs weight, food, water consumption and serum total protein, alanine and aspartate aminotransferase activity. The preventive index in doses of 40 and 80 mg/kg/BW of Bunium percicum Boiss.essential oil was 37.98% and 59.21%, respectively in the indomethacin -induced ulcer model (P<0.05). In the model of ethanol -induced ulcer, the preventive index in doses of 40 and 80 mg/kg of Bunium percicum Boiss. essential oil was 12.40% and 22.05%, respectively (P<0.05). Conclusion: The essential oil of Bunium percicum Boiss is completely ‘‘safe’’ and at the doses of 40 and 80mg/kg/bw significantly prevent gastric ulcers in animal model.

Page 1 from 1     

مجله دانشگاه علوم پزشکی گرگان Journal of Gorgan University of Medical Sciences
Persian site map - English site map - Created in 0.22 seconds with 26 queries by YEKTAWEB 4732
Creative Commons License
This work is licensed under a Creative Commons — Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)